|
SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Chief Executive Officer Stuart Ashman resigns after being suspended by the board ‘pending an investigation into matters relating to his conduct’. SkinBioTherapeutics provides ‘no further comment’ on the subject of the probe, saying it is ‘undertaking a full investigation, supported by its professional advisors’. Non-Executive Chair Martin Hunt becomes executive chair temporarily while the company looks for an interim CEO and then new permanent CEO. Back in October, Chief Operating Officer Simon Hewitson had left, with his duties taken over by Ashman and Finance Director Emily Bertram. Current stock price: 14.49 pence, down 26% in London early Friday 12-month change: down 20% Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
